News Industry News China Interventional Cardiovascular Device Industry Report, 2014-2017 May 27, 2015
News Conference News EuroPCR 2015 Studies Provide Encouraging Results for DCB in Long SFA Lesions Caitlin E. Cox May 22, 2015
News Conference News EuroPCR 2015 Trials Explore the Potential of Biodegradable-Polymer Stents Caitlin E. Cox May 21, 2015
News Industry News STENTYS: First Clinical Experience with Xposition shows 100% implantation success, Confirms Ease of Use May 20, 2015
News Industry News QT Vascular Announces First Patients Enrolled In Clinical Study Of Chocolate Touch™ PTCA Coronary Drug-Coated Balloon May 20, 2015
News Industry News Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions May 20, 2015
News Conference News EuroPCR 2015 MASTER: Biodegradable-Polymer DES Tested Against BMS in STEMI Caitlin E. Cox May 20, 2015
Presentation EuroPCR 2015 Five-Year Follow-up of Safety and Efficacy of the Resolute Zotarolimus-Eluting Stent: Insights from the RESOLUTE Global Clinical Trial Program in Approximately 8000 Patients Presenter: Sigmund Silber May 19, 2015
News Industry News New Data Presented At EuroPCR 2015 Demonstrate Strong Performance Of The SYNERGY™ Bioabsorbable Polymer Stent System Over Four Years May 19, 2015
News Industry News EuroPCR Late-Breaking Clinical Trials: MiStent SES® Shows Clinical Superiority over Market-Leader Xience V in Propensity Analysis at One and Three Years Post-Treatment May 19, 2015
News Industry News Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease May 19, 2015
Presentation Fellows 2015 Drug-Eluting Stents: Past, Present, and Future Presenter: Manish A. Parikh, Roxana Mehran, Gregg W. Stone May 15, 2015
News Industry News NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting May 04, 2015
News Industry News STENTYS' Next-Generation of Self-Apposing Stent System Receives CE Marking Ahead of Plan April 28, 2015
News Industry News New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months April 28, 2015